- Home
- FTRE vs GSL Comparison
FTRE vs GSL Comparison
Compare FTRE & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- GSL
- Stock Information
- Founded
- FTRE 1996
- GSL 2007
- Country
- FTRE United States
- GSL Greece
- Employees
- FTRE N/A
- GSL N/A
- Industry
- FTRE Medical Specialities
- GSL Marine Transportation
- Sector
- FTRE Health Care
- GSL Consumer Discretionary
- Exchange
- FTRE Nasdaq
- GSL Nasdaq
- Market Cap
- FTRE 864.4M
- GSL 1.0B
- IPO Year
- FTRE N/A
- GSL 2006
- Fundamental
- Price
- FTRE $9.88
- GSL $34.87
- Analyst Decision
- FTRE Hold
- GSL Strong Buy
- Analyst Count
- FTRE 9
- GSL 1
- Target Price
- FTRE $13.31
- GSL $39.00
- AVG Volume (30 Days)
- FTRE 1.4M
- GSL 406.6K
- Earning Date
- FTRE 11-05-2025
- GSL 11-10-2025
- Dividend Yield
- FTRE N/A
- GSL 7.20%
- EPS Growth
- FTRE N/A
- GSL 23.53
- EPS
- FTRE N/A
- GSL 11.07
- Revenue
- FTRE $2,759,900,000.00
- GSL $747,044,000.00
- Revenue This Year
- FTRE $0.47
- GSL $4.58
- Revenue Next Year
- FTRE N/A
- GSL N/A
- P/E Ratio
- FTRE N/A
- GSL $3.12
- Revenue Growth
- FTRE 1.88
- GSL 6.50
- 52 Week Low
- FTRE $3.97
- GSL $17.73
- 52 Week High
- FTRE $25.05
- GSL $35.59
- Technical
- Relative Strength Index (RSI)
- FTRE 45.63
- GSL 74.79
- Support Level
- FTRE $10.89
- GSL $33.17
- Resistance Level
- FTRE $12.07
- GSL $34.84
- Average True Range (ATR)
- FTRE 0.97
- GSL 0.96
- MACD
- FTRE -0.13
- GSL 0.42
- Stochastic Oscillator
- FTRE 10.15
- GSL 88.43
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.